These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19327923)

  • 41. [New reports on estrogen therapy. Increased risk of breast cancer; no effects on Alzheimer disease].
    Flam F
    Lakartidningen; 2000 May; 97(18):2166-9. PubMed ID: 10850046
    [No Abstract]   [Full Text] [Related]  

  • 42. Clarifying the hazards of HRT.
    Park A
    Time; 2010 Nov; 176(18):20. PubMed ID: 21053439
    [No Abstract]   [Full Text] [Related]  

  • 43. By the way, doctor. What happened to tibolone--the estrogen alternative we heard about a while ago? Did it turn out not to be effective?
    Robb-Nicholson C
    Harv Womens Health Watch; 2004 Apr; 11(8):8. PubMed ID: 15100062
    [No Abstract]   [Full Text] [Related]  

  • 44. Tibolone in older postmenopausal women.
    Chlebowski RT; Prentice R
    N Engl J Med; 2008 Nov; 359(20):2172-3; author reply 2173. PubMed ID: 19005202
    [No Abstract]   [Full Text] [Related]  

  • 45. Tibolone, blood pressure and obesity.
    Roshan J; Ganesh A
    Natl Med J India; 2002; 15(3):180. PubMed ID: 12186341
    [No Abstract]   [Full Text] [Related]  

  • 46. [Tibolone-induced hepatotoxicity].
    Blanco Sampascual S; de Las Heras Niño B; Cabezudo Gil P; Ruiz Eguiluz P; Orive Cura V
    Gastroenterol Hepatol; 2002 Apr; 25(4):274. PubMed ID: 11975880
    [No Abstract]   [Full Text] [Related]  

  • 47. Endometrial cancer and hormone-replacement therapy.
    Wiegratz I; Kuhl H
    Lancet; 2005 Jul 16-22; 366(9481):201-2. PubMed ID: 16023504
    [No Abstract]   [Full Text] [Related]  

  • 48. Complex endometrial hyperplasia in the context of tibolone administration.
    Kane SC; Quinn MA
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):338-9. PubMed ID: 19566575
    [No Abstract]   [Full Text] [Related]  

  • 49. Re: Should observational studies be a thing of the past?
    Weiss NS
    J Natl Cancer Inst; 2008 Aug; 100(15):1117; author reply 1117-8. PubMed ID: 18664651
    [No Abstract]   [Full Text] [Related]  

  • 50. Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125.
    Davies AP; Oram D
    Br J Obstet Gynaecol; 1994 Jul; 101(7):632-3. PubMed ID: 8043545
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
    Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
    Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tibolone: how does its mechanism of action translate into clinical effects.
    Kenemans P
    Maturitas; 2004 Aug; 48 Suppl 1():S1-3. PubMed ID: 15337240
    [No Abstract]   [Full Text] [Related]  

  • 53. [Is estrogen replacement therapy contraindicated in breast cancer?].
    Iversen OE
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):611-2. PubMed ID: 16505873
    [No Abstract]   [Full Text] [Related]  

  • 54. Tibolone-induced acute hepatitis: Well-known drug, little-known complication.
    Macedo G; Silva M; Vilas-Boas F; Lopes S; Peixoto A; Carneiro F
    Gastroenterol Hepatol; 2017 Apr; 40(4):298-300. PubMed ID: 27093896
    [No Abstract]   [Full Text] [Related]  

  • 55. Is mammographic density, as currently measured, a robust surrogate marker for breast cancer?
    Yaffe M; Hendrix S; Pike M; Santen R; Eden J; Genazzani A
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():17-21. PubMed ID: 16112951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The short-term effect of increased body weight in menopausal Chinese women taking tibolone.
    Wang PH; Yen MS; Chao KC; Liu CM; Lee WL
    Maturitas; 2008 Mar; 59(3):281-2; author reply 282-3. PubMed ID: 18281168
    [No Abstract]   [Full Text] [Related]  

  • 57. Should observational studies be a thing of the past?
    Pritchard KI
    J Natl Cancer Inst; 2008 Apr; 100(7):451-2. PubMed ID: 18364499
    [No Abstract]   [Full Text] [Related]  

  • 58. [Estrogen replacement therapy and breast cancer].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1045; author reply 1045. PubMed ID: 15852091
    [No Abstract]   [Full Text] [Related]  

  • 59. Hormone replacement therapy and gallstone disease: a real association.
    Dhiman RK; Chawla YK
    Digestion; 2008; 77(1):1-3. PubMed ID: 18212500
    [No Abstract]   [Full Text] [Related]  

  • 60. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.